Riskpilot← Back to searchSign inGet full accessDTL-Genetics A/S
A/SActiveCVR 15113685Industrivej 44Wholesale of live animals · NACE 4623Est. 19914 employees
Revenue 2024
DKK 11,5M
-76% vs 2023
EBITDA margin
54.4%
-73% vs 2023
Equity ratio
77.7%
Financial strength
Net profit 2024
DKK 8,2M
-21% vs 2023
| Revenue | DKK 11,5M | -76% |
| EBITDA | DKK 6,3M | -73% |
| Net profit | DKK 8,2M | -21% |
| Total assets | DKK 45,2M | -53% |
| Equity | DKK 35,2M | +5% |
| Employees | 4 | — |
Legal name
DTL-Genetics A/S
CVR number
15113685
Legal form
Aktieselskab
NACE code
4623 · Wholesale of live animals
Founded
1. april 1991
Share capital
DKK 500.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør, af et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med opformering af svin, svineavl og dermed beslægtet virksomhed og efter bestyrelsens bestemmelse anden virksomhed, som står i naturlig forbindelse hermed.
Address
Industrivej 44
Phone
+4574675526
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 19.586 | 19.481 | — | 24.015 | 25.025 | 25.183 | 35.291 | 33.195 | 24.651 | 34.562 | 47.473 | 11.502 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -15.024 | -15.586 | -15.403 | -15.098 | -16.612 | -17.744 | -19.737 | -23.295 | -22.847 | -22.240 | -24.094 | -5.247 |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.562 | 3.895 | 4.685 | 8.917 | 8.413 | 7.439 | 15.553 | 9.900 | 1.804 | 12.322 | 22.787 | 6.255 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 2.357 | 2.301 | -2.479 | -3.181 | -3.697 | -4.401 | -4.973 | -6.304 | -7.164 | -7.930 | -7.944 | -523 |
| EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.205 | 1.593 | 2.205 | 5.736 | 4.716 | 3.038 | 10.580 | 3.596 | -5.360 | 4.392 | 14.843 | 5.732 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 685 | 428 | 25 | 631 | 975 | 2.152 | 4.568 | 2.392 | 1.940 | 471 | -829 | -39 |
| Profit before tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.890 | 2.022 | 5.960 | 6.372 | 5.691 | 5.171 | 15.148 | 5.988 | -3.420 | 4.863 | 14.014 | 5.693 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 734 | 485 | 1.506 | 1.238 | 1.120 | 908 | 2.359 | 1.387 | -963 | 873 | 3.571 | -1.253 |
| Net profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.156 | 1.537 | 4.454 | 5.134 | 4.571 | 4.263 | 12.789 | 4.601 | -2.457 | 3.990 | 10.443 | 8.220 |
| Item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.773 | 61.507 | 62.101 | 60.199 | 56.791 | 65.962 | 98.548 | 106.845 | 107.397 | 89.816 | 95.456 | 45.235 |
| Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 15.233 | 15.193 | 16.765 | 18.512 | 19.233 | 20.071 | 28.860 | 28.461 | 21.004 | 24.994 | 33.437 | 35.156 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.347 | 8.209 | 10.921 | 11.231 | 9.296 | 7.829 | 11.948 | 17.746 | 21.586 | 18.933 | 13.074 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38.074 | 37.863 | 34.130 | 30.149 | 27.949 | 37.519 | 57.395 | 59.564 | 64.338 | 44.857 | 47.698 | 9.986 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.421 | 46.072 | 45.051 | 41.380 | 37.245 | 45.348 | 69.342 | 77.310 | 85.924 | 63.790 | 60.772 | 9.986 |
EBITDA margin
54.4%
This company
15.8%
Market median
+244% vs market
19992024
Equity ratio
77.7%
This company
38.2%
Market median
+103% vs market
19992024
Return on equity
23.4%
This company
18.4%
Market median
+27% vs market
19992024
Net profit margin
71.5%
This company
8.1%
Market median
+783% vs market
19992024
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
19992024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
19992024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via CVR / Virk · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via CVR / Virk · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via CVR / Virk · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via CVR / Virk · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via CVR / Virk · Period 2007-01-01 – 2007-12-31
- Annual report 2006Filed via CVR / Virk · Period 2006-01-01 – 2006-12-31
- Annual report 2005Filed via CVR / Virk · Period 2005-01-01 – 2005-12-31
- Annual report 2004Filed via CVR / Virk · Period 2004-01-01 – 2004-12-31
- Annual report 2003Filed via CVR / Virk · Period 2003-01-01 – 2003-12-31
- Annual report 2002Filed via CVR / Virk · Period 2002-01-01 – 2002-12-31
- Annual report 2001Filed via CVR / Virk · Period 2001-01-01 – 2001-12-31
- Annual report 2000Filed via CVR / Virk · Period 2000-01-01 – 2000-12-31
- Annual report 1999Filed via CVR / Virk · Period 1999-01-01 – 1999-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ET | Audit | 1991 | — | — |
| Audit | 1991 | — | — | |
MW Management | Management | 2026 | — | — |
TK Management | Management | 2015 | — | — |
CP | Audit | 1991 | — | — |
PJ Management | Management | 1991 | — | — |
PE Management | Management | 1991 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1991 | — | — | |
| Board of Directors | 1991 | — | — | |
| Board of Directors | 1991 | — | — | |
| Chairman | 2019 | — | — | |
| Deputy Chairman | 2025 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2026 | — | — | |
| Deputy Chairman | 2026 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 1991 | — | — | |
| Board of Directors | 1991 | — | — | |
| Chairman | 1991 | — | — | |
| Board of Directors | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Danish Genetics Holding ApS | Company | 100.0% | 100.0% | 2025 |
ENGGAARDEN INVEST ApS | Company | 100.0% | 100.0% | 2019 |
PRAMHUS INVEST ApS | Company | 10.0% | 10.0% | 2015 |
| Individual | 25.0% | 25.0% | 2015 | |
SO-MA-RA Invest ApS | Company | 100.0% | 100.0% | 2022 |
DTL HOLDING A/S | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Danish Genetics Holding ApS
DTL-Genetics A/S Board members of DTL-Genetics A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| Revisor Dieter Priess, Nordwestdeutsche Treuhand | Audit | 0 companies |
| Mikael Wædeled Sigvardsen | Management | 0 companies |
| Thorsten Kammer Simonsen | Management | 0 companies |
| Christian Paulsen Petersen | Audit | 0 companies |
| Peter Jørgensen Jensen | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Laurits Pedersen | Board of Directors | 0 companies |
| Peter Pampel | Board of Directors | 0 companies |
| Ulf Svejgaard Poulsen | Board of Directors | 0 companies |
| Jes Gravgaard Jensen | Chairman | 0 companies |
| Niels Henrik Reventlow | Deputy Chairman | 0 companies |
| Anders Andersen | Chairman | 0 companies |
| Jeanette Wedel Simonsen | Board of Directors | 0 companies |
| Steen Agerbo Bødtker | Chairman | 0 companies |
| Mads Hans Kring | Deputy Chairman | 0 companies |
| Rafael Jacobus Henri Gerard Beeren | Chairman | 0 companies |
| Henrik Jessen Enderlein | Chairman | 0 companies |
| Kresten Philipsen | Board of Directors | 0 companies |
| Susanne Saul Stakemann | Chairman | 0 companies |
| Nicolaj Henrik Nørgaard | Board of Directors | 0 companies |